Enhancing the function of CAR T cells via a universal vaccine strategy

被引：0
|
作者：
Irvine, Darrell J. [1 ]
机构：
[1] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-IA37
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA37
引用
收藏
页数：1
相关论文
共 50 条
  • [21] An engineering strategy to target activated EGFR with CAR T cells
    Dobersberger, Markus
    Sumesgutner, Delia
    Zajc, Charlotte U.
    Salzer, Benjamin
    Laurent, Elisabeth
    Emminger, Dominik
    Sylvander, Elise
    Lehner, Elisabeth
    Teufl, Magdalena
    Seigner, Jacqueline
    Bobbili, Madhusudhan Reddy
    Kunert, Renate
    Lehner, Manfred
    Traxlmayr, Michael W.
    CELL REPORTS METHODS, 2024, 4 (04):
  • [22] Strategy for approving a universal flu vaccine
    Ben-Yedidia, Tamar
    Babecoff, Ron Marc
    Arnon, Ruth
    FUTURE VIROLOGY, 2017, 12 (04) : 163 - 169
  • [23] Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
    Henze, Janina
    Tacke, Frank
    Hardt, Olaf
    Alves, Frauke
    Al Rawashdeh, Wa'el
    CANCERS, 2020, 12 (06)
  • [24] Enhancing CAR T-Cell Function with Domains of Innate Immunity Sensors
    Mlakar, Tjasa
    Skrbinek, Mojca
    Fink, Tina
    Lainscek, Dusko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [25] ENHANCING CAR T CELL PERSISTENCE AND MEMORY THROUGH MODULATING MITOCHONDRIAL FUNCTION
    Rad, A. Hosseini
    Tan, G. Min Yi
    Poudel, A.
    McLellan, A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A42 - A42
  • [26] Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
    Durgin, Joseph S.
    Thokala, Radhika
    Johnson, Lexus
    Song, Edward
    Leferovich, John
    Bhoj, Vijay
    Ghassemi, Saba
    Milone, Michael
    Binder, Zev
    O'Rourke, Donald M.
    O'Connor, Roddy S.
    MOLECULAR THERAPY, 2022, 30 (03) : 1201 - 1214
  • [27] Generation of universal CAR T cells with a memory phenotype: safety and efficacy studies
    Pavlovic, K.
    Carmona, M. D.
    Maldonado, N.
    Cortijo, M.
    Molina, F. J.
    Justicia, P.
    Tristan, M.
    Corsi, G. I.
    Seemann, S. E.
    Gorodkin, J.
    Martin, F.
    Herrera, I. C.
    Benabdellah, K.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A131 - A132
  • [28] Assessment of efficacy and safety of universal αCD19-CAR T cells
    Maldonado-Perez, N.
    Tristan-Manzano, M.
    Martin-Guerra, R.
    Sanchez-Hernandez, S.
    Cortijo-Gutierrez, M.
    Ramos-Hernandez, I.
    Maranon, C.
    Herrera, C.
    Carmona, M. D.
    Benabdellah, K.
    Martin, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A72 - A72
  • [29] Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
    Clemens, E. Bridie
    van de Sandt, Carolien
    San Wong, Sook
    Wakim, Linda M.
    Valkenburg, Sophie A.
    VACCINES, 2018, 6 (02):
  • [30] Effective iPSC differentiation for generation of CAR T cells with canonical T cell phenotype and CAR T function.
    Wang, Zhiqiang
    McWilliams-Koeppen, Hellen
    Reza, Hernan
    Ostberg, Julie
    Wang, Xiuli
    Huynh, Christian
    Vyas, Vibhuti
    Chang, Wen-Chung
    Starr, Renate
    Wagner, Jamie
    Aguilar, Brenda
    Yang, Xin
    Wu, Xiwei
    Wang, Jinhui
    Chen, Wei
    Koelker-Wolfe, Ellery, II
    Seet, Christopher
    Montel-Hagen, Amelie
    Crooks, Gay M.
    Forman, Stephen
    Brown, Christine
    CANCER RESEARCH, 2021, 81 (13)
12345